Sigma-Aldrich offers raw materials with pedigree; P&G targets 5,700 non-manufacturing jobs;

> Sigma-Aldrich ($SIAL) says it is responding to higher regulatory scrutiny that its clients face by releasing 25 new raw materials to its portfolio that feature regulatory support documentation for every lot. Release

> Boehringer Ingelheim and BaroFold have struck a non-exclusive technology and commercial license option agreement in which Boehringer will acquire a laboratory-scale reactor of BaroFold's Pressure Enabled Manufacturing Technology that can also be qualified for GMP use. Release

> Chemical distributor and supply chain services provider Doe & Ingalls has received a distilled spirits plant permit, which allows the company to warehouse and ship tax-free ethyl alcohol (ethanol). Doe & Ingalls will serve its customers through its three bonded service centers in California, North Carolina and Maryland. Item

> HumanZyme will provide HumanKine growth factors and cytokines to PacificGMP to manufacture recombinant human proteins intended for human clinical use. Item

And Finally... Procter & Gamble ($PG) will whack 5,700 non-manufacturing jobs to save money but expects to increase its manufacturing production 5%. Release

Suggested Articles

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

The FDA recently asked five drug manufacturers to recall the commonly used diabetes med metformin. With COVID-19 raging, is metformin just the start?

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.